TPD Summit Europe
Discover how Catalent is pushing the boundaries of drug development at the 5th TPD & Induced Proximity Summit Europe. Join us from March 25-27, 2025, in London, where we’ll showcase our innovative early-phase drug development solutions.
Learn more about our role in pioneering new therapies and enhancing drug delivery systems as we connect with industry leaders to advance protein degradation and proximity therapeutics.
Date: March 25-27, 2025
Location: London
JOIN US!
Meet with Catalent experts to gain key insights on overcoming drug product development and manufacturing challenges for oral bifunctional targeted protein degraders.
Complete the form to schedule a meeting with our experts!
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.
